Effectdossier · gearchiveerd kwartaal
GLUE
Monte Rosa Therapeutics, Inc. · Healthcare · Biotechnology
18Gevolgde houders
+2Δ houders
20.02MGehouden aandelen
$148.32MGerapporteerde waarde
+2Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +12.5% ·
aandelenstroom -6.0% ·
netto nieuwe posities +11.1%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | -3 | 40.75M | $985.52M | +5 | −8 |
| Q1 2026 | 84 | +11 | 37.29M | $613.27M | +14 | −3 |
| Q4 2025 | 73 | -1 | 26.21M | $411.01M | +1 | −2 |
| Q3 2025 | 18 | +2 | 20.02M | $148.32M | +2 | — |
| Q2 2025 | 13 | +1 | 20.51M | $92.50M | +1 | — |
| Q1 2025 | 9 | -3 | 9.96M | $46.20M | +1 | −4 |
| Q4 2024 | 12 | +2 | 11.82M | $82.01M | +2 | — |
| Q3 2024 | 9 | +2 | 9.48M | $50.23M | +2 | — |
| Q2 2024 | 7 | — | 8.29M | $30.99M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 4.64M | -26.7% | $34.36M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 4.64M | -26.7% | $34.36M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 2.99M | -4.8% | $22.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 2.99M | -4.8% | $22.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 2.99M | -4.8% | $22.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.81M | +22.9% | $20.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.81M | +22.9% | $20.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 2.81M | +22.9% | $20.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 1.15M | +2.4% | $8.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passief) | 1.15M | +2.4% | $8.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Marshall Wace ✦ | 902.83K | +102.4% | $6.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Marshall Wace ✦ | 902.83K | +102.4% | $6.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Marshall Wace ✦ | 902.83K | +102.4% | $6.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (passief) | 846.77K | +1.8% | $6.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Millennium Management ✦ | 444.94K | +588.4% | $3.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 395.73K | -35.7% | $2.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 161.48K | -32.7% | $1.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 158.52K | -29.5% | $1.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | Wellington Management ✦ | 158.52K | -29.5% | $1.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | Wellington Management ✦ | 158.52K | -29.5% | $1.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 101.14K | — | $749,477 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Goldman Sachs Group ✦ | 101.14K | — | $749,477 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Point72 Asset Management ✦ | 90.42K | Nieuw | $670,005 | 0.0% | New | 1 | SEC ↗ |
| 44 | Citadel Advisors ✦ | 51.01K | -34.5% | $377,976 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | Citadel Advisors ✦ | 51.01K | -34.5% | $377,976 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 46 | D. E. Shaw & Co. ✦ | 50.21K | Nieuw | $372,078 | 0.0% | New | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $670,005 | 0.0% |
| D. E. Shaw & Co. | $372,078 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 188 houders, 86.88M aandelen, $1.31B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API